Forbes-Tate
Forbes-Tate filed a Q3 report for National Association of Proton Therapy on October 19, 2025, reporting $60,000 in lobbying income.
Lobbying for National Association of Proton Therapy · Non-profit organization focused on access to Proton Therapy
Issues pertaining to veterans' access to proton therapy.
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
Issues related to continued access to and provider reimbursement for proton beam therapy; Issues related to the Fiscal Year 2026 Labor-HHS appropriations process.